STOCKWATCH
·
 Medicinal Chemicals and Botanical Products
DelistingApr 24, 2026, 04:37 PM

Mannatech receives Nasdaq delisting notice for $7.7M equity deficit

AI Summary

Mannatech, Inc. received a notice from Nasdaq on April 20, 2026, indicating non-compliance with the minimum stockholders' equity requirement of $2,500,000. As of December 31, 2025, the company reported a stockholders' equity deficit of $5,223,000, a shortfall of approximately $7.7 million. The notice does not result in immediate delisting, and Mannatech has until June 4, 2026, to submit a plan to regain compliance, with a potential extension until October 17, 2026.

Key Highlights

  • Mannatech received a Nasdaq notice for non-compliance with Listing Rule 5550(b)(1).
  • The company's stockholders' equity was ($5,223,000) as of Dec 31, 2025, below the $2,500,000 minimum.
  • This represents a deficiency of approximately $7.7 million.
  • Mannatech has until June 4, 2026, to submit a compliance plan to Nasdaq.
  • If accepted, an extension until October 17, 2026, may be granted to regain compliance.
MTEX
Medicinal Chemicals and Botanical Products
MANNATECH INC

Price Impact